Arboretum Ventures
Arboretum Ventures is a Michigan-based venture capital firm investing in medical technology and healthcare companies.
Business Model:
Revenue: $16.4M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Arboretum Ventures Information
Geographic Data
Address: 303 Detroit St
City: Ann Arbor
State: MI
Zip: 48104
Country: US
Financial Info
Stage:
Raised Last:
$5M
Raised Total:$5M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Arboretum Ventures is a Michigan-based venture capital firm. It specializes in seed-stage, early-stage, mid-stage investments, and growth capital. The company seeks to invest in healthcare sector with a focus on services, medical devices, diagnostics; healthcare information technology, therapeutics, technology based healthcare services, and life science tools. The firm invests throughout the United States with a focus on Midwest and Michigan. It seeks to invest in companies with equity investment between $5 million and $15 million. Arboretum Ventures Jan Garfinkle in 2002 and is headquartered in Michigan.
Contact Phone:
+17349983688
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2015 | Delphinus Medical Technologies | Series C | 0 |
| 12/2020 | Pear Therapeutics | Series D | 0 |
| 9/2013 | Delphinus Medical Technologies | Series B | 11M |
| 9/2022 | Delphinus Medical Technologies | Series D | 0 |
| 7/2016 | nVision Medical | Series B | 12M |
| 2/2012 | Cervilenz | Series E | 2M |
| 9/2013 | Adavium | Private Equity Round | 20M |
| 5/2008 | Esperion | Series A | 22.8M |
| 7/2008 | Hicuity Health | Series B | 5M |
| 10/2008 | BAROnova | Series B | 0 |
| 7/2010 | Delphinus Medical Technologies | Series A | 8M |
| 5/2006 | Uptake Medical | Series A | 9M |
| 10/2021 | Akadeum Life Sciences | Series B | 0 |
| 6/2012 | Tangent Medical Technologies | Venture Round | 7.9M |
| 5/2012 | Sonitus Medical | Series D | 25M |
| 12/2021 | Pear Therapeutics | Post-IPO Equity | 0 |
| 10/2015 | Intellicyt | Venture Round | 0 |
| 10/2014 | My Health Direct | Venture Round | 8M |
| 5/2010 | CardioMEMS | Venture Round | 0 |
| 10/2009 | CardioMEMS | Series F | 0 |
| 11/2003 | NeoGuide Systems | Series B | 0 |
| 6/2016 | Strata Oncology | Series A | 12M |
| 11/2022 | Boomerang Medical | Series A | 0 |
| 5/2013 | Intellicyt | Venture Round | 0 |
| 3/2012 | Uptake Medical | Series C | 40.3M |
| 1/2021 | EQRx | Series B | 500M |
| 11/2003 | CardioMEMS | Series B | 0 |
| 12/2018 | SonarMD | Series A | 10M |
| 6/2017 | Swift Biosciences | Series D | 12.2M |
| 5/2009 | Cervilenz | Series A | 4M |
| 11/2012 | Tangent Medical Technologies | Series B | 8.6M |
| 7/2005 | HealthMedia | Venture Round | 2M |
| 10/2021 | Convergent Dental | Series C | 0 |
| 9/2021 | Francis Medical | Series B | 0 |
| 4/2011 | My Health Direct | Series B | 4M |
| 8/2014 | Rethink First | Series C | 10M |
| 7/2010 | Uptake Medical | Series B | 17.5M |
| 1/2006 | BAROnova | Series A | 6.5M |
| 1/2021 | Koya Medical | Series A | 0 |
| 1/2020 | EQRx | Series A | 200M |
| 8/2005 | KFx Medical | Series A | 6.2M |
| 5/2017 | Aira Tech Corp. | Series B | 12M |
| 7/2008 | Accuri Cytometers | Series C | 13M |
| 12/2018 | Francis Medical | Series A | 18M |
| 6/2016 | SI-BONE | Venture Round | 26M |
| 5/2013 | Fidelis SeniorCare | Series A | 20.5M |
| 10/2011 | NxThera | Series B | 0 |
| 10/2011 | Cervilenz | Venture Round | 3.5M |
| 3/2018 | BioIQ | Venture Round | 26.5M |
| 9/2013 | Advance Medical | Series B | 20M |
| 8/2007 | Mirabilis Medical | Series A | 10.5M |
| 4/2019 | Fifth Eye | Series A | 11.5M |
| 11/2016 | ConcertoCare | Venture Round | 30M |
| 4/2014 | NeuMoDx Molecular | Series B | 21M |
| 4/2013 | Esperion | Venture Round | 33M |
| 1/2021 | Jumpcode Genomics | Series B | 21M |
| 2/2016 | Pear Therapeutics | Series A | 20M |
| 5/2018 | Strata Oncology | Series B | 26M |
| 2/2007 | Inogen | Series D | 22M |
| 11/2010 | PathCentral | Series B | 10M |
| 4/2007 | Accuri Cytometers | Series B | 5M |
| 1/2017 | Ebb Therapeutics | Series B | 0 |
| 11/2021 | ViaLase | Series A | 27.3M |
| 2/2012 | Cervilenz | Series A | 8.3M |
| 9/2021 | Allay Therapeutics | Series C | 60M |
| 1/2018 | Pear Therapeutics | Series B | 50M |
| 10/2014 | Cardiac Dimensions | Series A | 8.5M |
| 9/2020 | Cardiac Dimensions | Series C | 17.5M |
| 7/2013 | ArborMetrix | Series B | 7M |
| 3/2015 | Cardiac Dimensions | Equity | 15.2M |
| 10/2010 | Accuri Cytometers | Series E | 6M |
| 11/2011 | Tangent Medical Technologies | Series A | 4.5M |
| 8/2009 | Accuri Cytometers | Series D | 4M |
| 1/2020 | Health Scholars | Series B | 0 |
| 7/2021 | Strata Oncology | Series C | 0 |
| 6/2021 | Navv Systems | Seed | 3.2M |
| 2/2013 | BAROnova | Series C | 27.3M |
| 2/2006 | Hicuity Health | Series A | 0 |
| 4/2011 | Wellfount | Series A | 6M |
| 11/2003 | Asterand | Series C | 3M |
| 12/2022 | BrightSpec | Series C | 18.4M |
| 3/2019 | Lucina Health | Seed Round | 0 |
| 3/2016 | ArborMetrix | Series B | 0 |
| 1/2023 | Cardiac Dimensions | Series D | 35M |
| 2/2022 | Koya Medical | Series B | 0 |
| 11/2011 | Hicuity Health | Series D | 0 |
| 4/2018 | Cardiac Dimensions | Series B | 39M |
| 8/2008 | HandyLab | Series D | 19.2M |
| 10/2021 | Boomerang Medical | Seed Round | 3M |
| 8/2022 | Navv Systems | Equity | 5.5M |
| 3/2005 | Accuri Cytometers | Series A | 0 |
| 1/2019 | Pear Therapeutics | Series C | 64M |
| 9/2021 | RareCyte | Series G | 0 |
| 5/2022 | Enumera Molecular | Series A | 0 |
| 8/2007 | KFx Medical | Series B | 10M |
| 2/2021 | Flosonics | Venture Round | 0 |
| 5/2022 | Enumera Molecular | Series A | 0 |
| 2/2022 | Koya Medical | Series B | 0 |
| 12/2021 | Pear Therapeutics | Post-IPO Equity | 0 |
| 11/2021 | ViaLase | Series A | 0 |
| 10/2021 | Convergent Dental | Series C | 0 |
| 10/2021 | Akadeum Life Sciences | Series B | 0 |
| 9/2021 | Francis Medical | Series B | 0 |
| 9/2021 | Allay Therapeutics | Series C | 0 |
| 9/2021 | RareCyte | Series G | 0 |
| 7/2021 | Strata Oncology | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
